Health economics data specialist Context Matters and analyst IHS Markit have linked up to launch PriceCurrents, a global pricing tool for the pharmaceutical industry.
The tool integrates data from IHS Markit’s online pharmaceutical pricing database with reimbursement and regulatory data from Context Matters' Market Access Platform (MAP) into timeline visualizations, allowing users to spot links between the two.
Gustav Ando (pictured), Senior Director & Vice President for IHS Markit, comments: ‘The high level of change in the pharmaceutical industry makes it challenging for manufacturers and payers to come to a consensus on price-value data. PriceCurrents delivers a mission-critical tool to the industry that enables rapid analysis and analytical insights on how health technology assessment (HTA) and regulatory approvals shape the pricing of drug assets'.
Web sites: www.contextmatters.com and www.ihsmarkit.com .